United States · FDA National Drug Code directory
TIADYLT ER
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-745_16e01600-83e9-4996-8b2b-c175d92a205a
- Product NDC
- 68382-745
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- diltiazem hydrochloride
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171108
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-745-01) · 68382-745-01
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-745-05) · 68382-745-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-745-06) · 68382-745-06
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-745-10) · 68382-745-10
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-745-16) · 68382-745-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →